Form ARS - Annual Report to Security Holders:
SEC Accession No. 0000950170-25-055757
Filing Date
2025-04-18
Accepted
2025-04-18 08:10:06
Documents
1
Period of Report
2024-12-31
Effectiveness Date
2025-04-18

Document Format Files

Seq Description Document Type Size
1 ARS clsd_ars_2024.pdf ARS 2484719
  Complete submission text file 0000950170-25-055757.txt   3423870
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

EIN.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-37783 | Film No.: 25849261
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)